Global Kidney Fibrosis Treatment Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027

MarketResearch.biz, in its upcoming report titled, “Global Kidney Fibrosis Treatment Market Trends, Applications, Analysis, Growth, and Forecast to 2027”, offers in-depth insights, revenue details, and other vital information regarding the global kidney fibrosis treatment market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report also offers insightful and detailed information regarding the various key players operating in the global kidney fibrosis treatment market, and their financials, apart from strategies, acquisitions & mergers, and market footprint. The global kidney fibrosis treatment market report has been segmented on the basis of therapeutics, end user, and region.

Request Covid - 19 Impact

Kidney fibrosis or renal fibrosis is an unavoidable consequence of excessive growth of extracellular matrix that occurs virtually in all types of chronic kidney diseases. Renal scarring results in the progression of loss of renal function, which leads to end-stage renal failure or need for kidney dialysis treatment or transplant. Obesity and smoking are the main causes for increasing incidence of kidney fibrosis globally.

Among the various therapeutic treatments in the market, angiotensin converting enzyme inhibitor is more widely used and revenue from sales of these types of drugs is expected to contribute significantly to growth of the global kidney fibrosis treatment market over the forecast period. Owing to rising disposable income among consumers globally, and rising awareness about accessibility to treatments in hospitals etc., revenue from angiotensin converting enzyme inhibitor is expected to continue its dominance over the forecast period.

Other factors fueling growth of this market include increasing aging population, income saved for long term basis, growing awareness about renal fibrosis treatment, and constant technological innovation leading to development of new, more advanced, safer and effective therapies. Government initiatives for development of novel drugs is expected to fuel growth of the global kidney fibrosis treatment market. Changing lifestyle and food habits are causing a rise in kidney fibrosis patient pools, which is expected to boost demand for kidney fibrosis treatment. Mounting health awareness and health concerns among the growing populations are the factors driving growth of the target market.

Point-of-care drug delivery systems, introduction of personalized medicines, mono-therapeutic approaches or combination therapies are the opportunities expected for growth of kidney fibrosis treatment market. However, high cost involved and failure of treatments are some factors restraining growth of the global kidney fibrosis treatment market to a certain extent. This is a trend expected to continue over the forecast period.

North America dominates the global kidney fibrosis treatment market in terms of revenue share, followed by the market in Europe due to large and increasing aging patient pool and improving health facilities globally. Asia Pacific is projected to be the fastest growing market over the forecast period due to increasing medical expenditure, rising medical treatment, and rise in disposable income.

Global Kidney Fibrosis Treatment Market Segmentation:

Segmentation on the basis of therapeutic:

• Angiotensin converting enzyme inhibitors
• Pirfenidone
• Renin inhibitors
• Angiotensin II receptor blockers
• Vasopeptidase inhibitors

Segmentation on the basis of end user:

• Clinics
• Hospitals
• Home based treatment

Region-wise segmentation

• Europe
• North America
• Asia Pacific
• Latin America
• Middle East & Africa.